Login / Signup

Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.

Sandra LockmerKatarina UttervallMuhammad KashifCarina SvärdKatarina MalmstenEvellyn Fletcher-TorresEvren AliciJohan LundHareth Nahi
Published in: American journal of hematology (2021)
Keyphrases
  • high dose
  • coronavirus disease
  • sars cov
  • stem cell transplantation
  • low dose
  • multiple myeloma
  • newly diagnosed
  • binding protein